MDoutlook Logo
Menu
Login
Let's Talk

Articles

MDoutlook® Delivers Precision Intelligence

Accelerating Precision Engagement with Medical KOLs
Article
php
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access To Your Target Healthcare ThoughtLeaders
Article
php
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Master your post-conference follow-up
Article
php
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Oncology Market Research: Hyper-Targeting Oncologists
Article
php
Oncology conferences such as American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) are critically important industry resources that create valuable opportunities to conduct oncology market research so that more life-saving cancer treatments can reach the patients who need them.  The European Society for Medical Oncology, or
Read more
The treatment landscape for prostate cancer is changing
Article
php
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
Driving impactful outcomes through precision intelligence
Article
php
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
Measuring value perceptions of Immunotherapy
Article
php
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
KPI Measurement Success
Article
php
In today’s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Identify rising stars amongst ThoughtLeaders
Article
php
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ‘rising stars’ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrow’s healthcare market. Similarly, clients are increasingly using MDOutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
Rapid insights on clinical impact of ASCO – Integration of new treatment regimens in CLL
Article
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPoll™ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
Accelerating Precision Engagement with Medical KOLs
Article
php
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access To Your Target Healthcare ThoughtLeaders
Article
php
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Master your post-conference follow-up
Article
php
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Oncology Market Research: Hyper-Targeting Oncologists
Article
php
Oncology conferences such as American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) are critically important industry resources that create valuable opportunities to conduct oncology market research so that more life-saving cancer treatments can reach the patients who need them.  The European Society for Medical Oncology, or
Read more
The treatment landscape for prostate cancer is changing
Article
php
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
Driving impactful outcomes through precision intelligence
Article
php
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
Measuring value perceptions of Immunotherapy
Article
php
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
KPI Measurement Success
Article
php
In today’s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Identify rising stars amongst ThoughtLeaders
Article
php
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ‘rising stars’ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrow’s healthcare market. Similarly, clients are increasingly using MDOutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
Rapid insights on clinical impact of ASCO – Integration of new treatment regimens in CLL
Article
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPoll™ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
Accelerating Precision Engagement with Medical KOLs
Article
php
Would you like timely critical insights that enhance your businesses in a competitive marketplace? We’ve engaged 87,000 physicians worldwide in our active community of validated and active treaters that includes valuable Medical Key Opinion Leaders and ThoughtLeaders.
Read more
Immediate Access To Your Target Healthcare ThoughtLeaders
Article
php
Immediate Access to Your Target Healthcare ThoughtLeaders It can be a lengthy and challenging process to identify the right healthcare ThoughtLeaders to serve as advocates for pharmaceutical brands. At MDOutlook, we make it easy to identify, engage and deploy Healthcare ThoughtLeaders who can drive value for companies. Our precision engagement
Read more
Master your post-conference follow-up
Article
php
Measuring the impact of data announcements is of importance, tracking follow-up activity from a conference is of even greater importance and should not be overlooked when assessing the overall influence and reach of your messages. Having helped numerous biopharmaceutical companies track impact from their messaging activities, our experienced team shares
Read more
Oncology Market Research: Hyper-Targeting Oncologists
Article
php
Oncology conferences such as American Society of Clinical Oncology (ASCO) and American Society of Hematology (ASH) are critically important industry resources that create valuable opportunities to conduct oncology market research so that more life-saving cancer treatments can reach the patients who need them.  The European Society for Medical Oncology, or
Read more
The treatment landscape for prostate cancer is changing
Article
php
Cabazitaxel was presented as an option for men with metastatic castration-resistant prostate cancer (mCRPC) who have progressed after treatment with docetaxel and an androgen signaling-targeted agent according to data presented at ESMO 2019. The results showed a significant survival benefit for Cabazitaxel in third line over enzalutamide or abiraterone where
Read more
Driving impactful outcomes through precision intelligence
Article
php
MDOutlook empowers confident business decisions with valuable precision insights and actionable intelligence. At the recent 2019 annual meeting of the Association of Residents in Radiation Oncology (ASTRO), one of our clients was interested in recruiting very specific radiation oncologists (recruited to a very tight inclusion criteria) to an event at
Read more
Measuring value perceptions of Immunotherapy
Article
php
ImmunoOncology (IO) expands the treatment possibilities and provides substantial clinical benefit, especially in patients who had little to no effective treatment options less than a decade ago. IO features prominently at the 2019 annual European Society for Medical Oncology (ESMO) annual congress in Barcelona where agenda items will cover topics
Read more
KPI Measurement Success
Article
php
In today’s climate, the imperative for new products or brands to achieve their full potential quickly has never been greater. Key to achieving success is measuring and communicating progress, both internally and externally. Tracking your product is an iterative process of measuring, managing and monitoring key performance indicators (KPIs) for
Read more
Identify rising stars amongst ThoughtLeaders
Article
php
Increasingly, biopharmaceutical companies recognize the importance and value of identifying and engaging ‘rising stars’ since they are typically younger, tech-engaged, offer novel perspectives, future ThoughtLeaders and a window to tomorrow’s healthcare market. Similarly, clients are increasingly using MDOutlook precision intelligence to identify the most relevant rising star ThoughtLeaders (TL; also
Read more
Rapid insights on clinical impact of ASCO – Integration of new treatment regimens in CLL
Article
php
After every major conference, MDOutlook provides valuable insights on the impact of new data presented. In our 3rd OncoPoll™ study following the 2019 ASCO conference, we looked at the oral presentations in CLL and researched how US and EU5 oncologists evaluated them. Even with these CLL presentations being on the
Read more
Three Ways to Identify and Activate ThoughtLeaders

3 Ways To Identify And Activate ThoughtLeaders Webinar

October 7, 2020 No Comments

In this webinar, we will help you (1) go deeper in identifying your ThoughtLeaders in a specific disease area, (2) to target your ThoughtLeaders for the right type of activity and (3) provide you the foundation for building stronger relationships with specific ThoughtLeaders and their influence networks.

Read More »
Webinar Cover

Performance Tracking To Stay Ahead Of The Curve On-Demand Webinar

August 18, 2020 No Comments

You need brand and market insights yesterday! You are not satisfied with the insights provided because each time you receive them, they are out of date. You want to stay one step ahead. In this webinar, we share ways that you can stay ahead by reacting in time through informed confident business decisions.

Read More »

Categories

Articles
Webinars
Launch Insights
Videos
Product Highlights

Archives

[archives type=monthly limit=10]

Links

FDA Drug information:
http://www.fda.gov/Drugs

European Medicines Agency:
http://www.ema.europa.eu/

Publication Research:
http://www.ncbi.nlm.nih.gov/pubmed

Clinical Trials Research:
http://www.clinicaltrials.gov/

© 2020 MDoutlook. All Rights Reserved.

MENU

Home   

Resources

Company

Insights in an Elevator

SOLUTIONS

ThoughtLeader Insights

Performance Tracking

Virtual Engagement

Pulse Research

Consultative Insights

LEGAL

Privacy Statement

Terms of Use

FOLLOW US

Facebook-f Twitter Linkedin